Cargando…

P16-39. T cell recognition of autologous and non-autologous HIV-1 protease peptides by HIV-1 infected patients undergoing PI therapy

Detalles Bibliográficos
Autores principales:	Moraes, SL, Muller, NG, Paula, MO, Arruda, MB, Brindeiro, RM, Alencar, R, Jamal, L, Kalil, J, Cunha-Neto, E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767768/ http://dx.doi.org/10.1186/1742-4690-6-S3-P268

Ejemplares similares

HIV-1 Autologous Antibody Neutralization Associates with Mother to Child Transmission
por: Baan, Elly, et al.
Publicado: (2013)

The role of NK cells in HIV-1 protection: autologous, allogeneic or both?
por: Hens, Jef, et al.
Publicado: (2016)

Highly Efficient Autologous HIV-1 Isolation by Coculturing Macrophage With Enriched CD4(+) T Cells From HIV-1 Patients
por: Xufré, Cristina, et al.
Publicado: (2022)

Interdependence of Inhibitor Recognition in HIV-1 Protease
por: Paulsen, Janet L., et al.
Publicado: (2017)

P18-13 LB. Immunogenicity of an autologous dendritic cell anti-HIV therapy in HIV-1 infected individuals
por: Yassine Diab, B, et al.
Publicado: (2009)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes
por: Su, B, et al.
Publicado: (2012)

The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization
por: Schorcht, Anna, et al.
Publicado: (2022)

P18-07. Ex vivo production of autologous HIV-1 to be used as immunogen in autologous dendritic cell-based therapeutic vaccine (clinical trial DCV02)
por: Gil, C, et al.
Publicado: (2009)

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
por: Willey, Suzanne, et al.
Publicado: (2011)

Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus
por: Mayr, LM, et al.
Publicado: (2012)

Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response against Autologous Virus
por: Mayr, Luzia M., et al.
Publicado: (2012)

Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
por: Muvarak, Nidal, et al.
Publicado: (2022)

Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials
por: Hompe, Eliza D., et al.
Publicado: (2020)

Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis
por: Liu, Baochi, et al.
Publicado: (2020)

Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
por: Yang, Yuhe R., et al.
Publicado: (2020)

The CD85j(+) NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
por: Scott-Algara, Daniel, et al.
Publicado: (2008)

Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen
por: Smith, Kellie N, et al.
Publicado: (2012)

Postnatally-transmitted HIV-1 variants are efficient at dendritic cell trans-infection and sensitive to autologous and heterologous neutralization
por: Fouda, GG, et al.
Publicado: (2012)

Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection
por: Mishra, Nitesh, et al.
Publicado: (2020)

TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4(+) T cells
por: Holder, Kayla A, et al.
Publicado: (2021)

Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
por: Laeremans, Thessa, et al.
Publicado: (2023)

HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets
por: Song, Rujun, et al.
Publicado: (2014)

HIV-1 protease-induced apoptosis
por: Rumlová, Michaela, et al.
Publicado: (2014)

Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection
por: Huber, Michael, et al.
Publicado: (2006)

Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways
por: Rong, Rong, et al.
Publicado: (2009)

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
por: Basu, Debby, et al.
Publicado: (2012)

HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms
por: Deshpande, Suprit, et al.
Publicado: (2016)

Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
por: Brouwer, Philip J. M., et al.
Publicado: (2021)

Use of the Autologous Membrane in Structured Rhinoplasty: An Alternative to Camouflaging and Filling
por: da S. Neto, Manoel P., et al.
Publicado: (2020)

Multiplex RT-PCR Amplification of HIV Genes to Create a Completely Autologous DC-Based Immunotherapy for the Treatment of HIV Infection
por: Tcherepanova, Irina, et al.
Publicado: (2008)

B- and T-lymphocyte number and function in HIV(+)/HIV(−) lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation
por: Bertoli, Diego, et al.
Publicado: (2016)

Thermostability of Well-Ordered HIV Spikes Correlates with the Elicitation of Autologous Tier 2 Neutralizing Antibodies
por: Feng, Yu, et al.
Publicado: (2016)

A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies
por: McCann, Chase D., et al.
Publicado: (2021)

Co-Immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8(+) T Cells
por: Jaworski, Juan Pablo, et al.
Publicado: (2012)

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth
por: Murphy, Megan K., et al.
Publicado: (2013)

Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies
por: Bale, Shridhar, et al.
Publicado: (2018)

HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells
por: Petkov, Stefan, et al.
Publicado: (2022)

Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2016)

Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints
por: Moreira, Juliana J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_alhqanr5um3pl0lvd3rdko871d